Skip to main content Accessibility help

Molecular Epidemiology and Risk Factors for Colonization by Vancomycin-Resistant Enterococcus in Patients with Hematologic Malignancies

  • N. G. Almyroudis (a1) (a2) (a3), A. J. Lesse (a2) (a4) (a5), T. Hahn (a1), G. Samonis (a3), P. A. Hazamy (a1), K. Wongkittiroch (a1) (a2), E. S. Wang (a1) (a2), P. L. McCarthy (a1), M. Wetzler (a1) and B. H. Segal (a1) (a6)...



To study the molecular epidemiology of vancomycin-resistant Enterococcus (VRE) colonization and to identify modifiable risk factors among patients with hematologic malignancies.


A hematology-oncology unit with high prevalence of VRE colonization.


Patients with hematologic malignancies and hematopoietic stem cell transplantation recipients admitted to the hospital.


Patients underwent weekly surveillance by means of perianal swabs for VRE colonization and, if colonized, were placed in contact isolation. We studied the molecular epidemiology in fecal and blood isolates by pulsed-field gel electrophoresis over a 1-year period. We performed a retrospective case-control study over a 3-year period. Cases were defined as patients colonized by VRE, and controls were defined as patients negative for VRE colonization. Case patients and control patients were matched by admitting service and length of observation time.


Molecular genotyping demonstrated the primarily polyclonal nature of VRE isolates. Colonization occurred at a median of 14 days. Colonized patients were characterized by longer hospital admissions. Previous use of ceftazidime was associated with VRE colonization (P < .001), while use of intravenous vancomycin and antibiotics with anaerobic activity did not emerge as a risk factor. There was no association with neutropenia or presence of colonic mucosal disruption, and severity of illness was similar in both groups.


Molecular studies showed that in the majority of VRE-colonized patients the strains were unique, arguing that VRE acquisition was sporadic rather than resulting from a common source of transmission. Patient-specific factors, including prior antibiotic exposure, rather than breaches in infection control likely predict for risk of fecal VRE colonization.


Corresponding author

State University of New York at Buffalo, Division of Infectious Diseases, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263 (


Hide All
1. Murdoch, DR, Mirrett, S, Harrell, LJ, Monahan, JS, Relier, LB. Sequential emergence of antibiotic resistance in enterococcal bloodstream isolates over 25 years. Antimicrob Agents Chemother 2002;46:36763678.
2. Matar, MJ, Tarrand, J, Raad, I, Rolston, KV. Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer. Am J Infect Control 2006;34:534536.
3. DiazGranados, CA, Jernigan, JA. Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection. J Infect Dis 2005;191:588595.
4. Weinstock, DM, Conlon, M, Iovino, C, et al. Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant. Biol Blood Marrow Transplant 2002;13:615621.
5. Calderwood, MS, Mauer, A, Tolentino, J, et al. Epidemiology of vancomycin-resistant enterococci among patients on an adult stem cell transplant unit: observations from an active surveillance program. Infect Control Hosp Epidemiol 2008;29:10191025.
6. Suntharam, N, Lankford, MG, Trick, WE, Peterson, LR, Noskin, GA. Risk factors for acquisition of vancomycin-resistant enterococci among hematology-oncology patients. Diagn Microbiol Infect Dis 2002;43:183188.
7. Hachem, R, Graviss, L, Hanna, H, et al. Impact of surveillance for vancomycin-resistant enterococci on controlling a bloodstream outbreak among patients with hematologic malignancy. Infect Control Hosp Epidemiol 2004;25:391394.
8. Ostrowsky, BE, Trick, WE, Sohn, AH, et al. Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med 2001;344:14271433.
9. Muto, CA, Jernigan, JA, Ostrowsky, BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus . Infect Control Hosp Epidemiol 2003;24:362386.
10. Borgen, K, Wasteson, Y, Kruse, H, Willems, RJL. Vancomycin-resistant Enterococcus faecium (VREF) from Norwegian poultry cluster with VREF from poultry from the United Kingdom and the Netherlands in an amplified fragment length polymorphism genogroup. Appl Environ Microbiol 2002;68:31333137.
11. McDougal, LK, Steward, CD, Killgore, GE, Chaitram, JM, McAllister, SK, Tenover, FC. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 2003;41:51135120.
12. Willems, RJ, Top, J, van Den Braak, N, et al. Host specificity of vancomycin-resistant Enterococcus faecium . J Infect Dis 2000; 182: 816823.
13. Woodford, N, Reynolds, R, Turton, J, et al. Two widely disseminated strains of Enterococcus faecalis highly resistant to genta-micin and ciprofloxacin from bacteraemias in the UK and Ireland. J Antimicrob Chemother 2003;52:711714.
14. Knaus, WA, Wagner, DP, Draper, EA, et al. The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991;100:16191636.
15. Winston, LG, Charlebois, ED, Pang, S, Bangsberg, DR, Perdreau-Remington, F, Chambers, HE Impact of a formulary switch from ticarcillin-clavulanate to piperacillin-tazobactam on colonization with vancomycin-resistant enterococci. Am J Infect Control 2004;32:462469.
16. Bradley, SJ. Control of glycopeptide-resistant enterococci in an oncology unit. Pharmacotherapy 2000;20:203S212S, discussion 224S-228S.
17. Smith, DW. Decreased antimicrobial resistance after changes in antibiotic use. Pharmacotherapy 1999;19:129S132S, discussion 133S-137S.
18. Nourse, C, Murphy, H, Byrne, C, et al. Control of a nosocomial outbreak of vancomycin resistant Enterococcus faecium in a paediatric oncology unit: risk factors for colonisation. Eur J Pediatr 1998;157:2027.
19. Price, CS, Paule, S, Noskin, GA, Peterson, LR. Active surveillance reduces the incidence of vancomycin-resistant enterococcal bacteremia. Clin Infect Dis 2003;37:921928.
20. Bischoff, WE, Reynolds, TM, Hall, GO, Wenzel, RP, Edmond, MB. Molecular epidemiology of vancomycin-resistant Enterococcus faecium in a large urban hospital over a 5-year period. J Clin Microbiol 1999;37:39123916.
21. Morris, JG Jr, Shay, DK, Hebden, JN, et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin: establishment of endemicity in a university medical center. Ann Intern Med 1995;123:250259.
22. Yoo, SJ, Sung, H, Cho, Y-U, Kim, M-N, Pai, CH, Kim, YS. Role of horizontal transfer of the transposon Tn1546 in the nosocomial spread of vanA vancomycin-resistant enterococci at a tertiary care hospital in Korea. Infect Control Hosp Epidemiol 2006;27: 10811087.
23. van Schaik, W, Top, J, Riley, DR, et al. Pyrosequencing-based comparative genome analysis of the nosocomial pathogen Enterococcus faecium and identification of a large transferable pathogenicity island. BMC Genomics 2010;11:239.
24. Rice, LB, Lakticovâ, V, Carias, LL, Rudin, S, Hutton, R, Marshall, SH. Transferable capacity for gastrointestinal colonization in Enterococcus faecium in a mouse model. J Infect Dis 2009; 199: 342349.
25. Dahms, RA, Johnson, EM, Statz, CL, Lee, JT, Dunn, DL, Beilman, GJ. Third-generation cephalosporins and vancomycin as risk factors for postoperative vancomycin-resistant enterococcus infection. Arch Surg 1998;133:13431346.
26. Fridkin, SK, Edwards, JR, Courval, JM, et al. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units. Ann Intern Med 2001;135:175183.
27. Tornieporth, NG, Roberts, RB, John, J, Hafher, A, Riley, LW. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. Clin Infect Dis 1996;23:767772.
28. Rice, LB, Hutton-Thomas, R, Lakticovâ, V, Helfand, MS, Donskey, CJ. Beta-lactam antibiotics and gastrointestinal colonization with vancomycin-resistant enterococci. J Infect Dis 2004; 189: 11131118.
29. Brandl, K, Plitas, G, Mihu, CN, et al. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 2008;455:804807.


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed